Evidence map›Paper›PMID 30466493›Full record

Trial reportCritical care (London, England)2018

Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study.

Toshikazu Abe, Hiroshi Ogura, Atsushi Shiraishi, Shigeki Kushimoto, Daizoh Saitoh, Seitaro Fujishima, Toshihiko Mayumi, Yasukazu Shiino, Taka-Aki Nakada, Takehiko Tarui and 20 more

2 registry-linked trialsOpen access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Critical care (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04438187 nacompletednot on this mapstarted 2021, after this paper: background citation

Trial of Antimicrobial Restraint in Presumed Pneumonia

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2021 to 2022Enrolled186ConditionsHealthcare-Associated Pneumonia, SepsisArmsantimicrobial initiation
NCT07096310 phase1 / phase2active not recruitingnot on this mapstarted 2024, after this paper: background citation

Comparison Between Carbapenems and Noncarbapenem Broad Spectrum Beta-lactam Antibiotics as Initial Antibiotic Therapy Against Sepsis in Burn Patients: A Prospective Study

TypeinterventionalSponsorAin Shams UniversityRan2024 to 2026Enrolled400ConditionsSepsisArmsMeropenem I.V. 2g as a 3 hour infusion every 8 hours, Tazocin (pipercillin/tazobactam)
3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 19 institutions in 1 country.

Toshikazu AbeDepartment of General Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. abetoshi111@gmail.com.
Hiroshi OguraDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Atsushi ShiraishiEmergency and Trauma Center, Kameda Medical Center, Kamogawa, Japan.
Shigeki KushimotoDivision of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Daizoh SaitohDivision of Traumatology, Research Institute, National Defense Medical College, Tokorozawa, Japan.
Seitaro FujishimaCenter for General Medicine Education, Keio University School of Medicine, Tokyo, Japan.
Toshihiko MayumiDepartment of Emergency Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Yasukazu ShiinoDepartment of Acute Medicine, Kawasaki Medical School, Kurashiki, Japan.
Taka-Aki NakadaDepartment of Emergency and Critical Care Medicine Chiba University Graduate School of Medicine, Chiba, Japan.
Takehiko TaruiDepartment of Trauma and Critical Care Medicine, Kyorin University School of Medicine, Tokyo, Japan.
Toru HifumiDepartment of Emergency and Critical Care Medicine, St. Luke's International Hospital, Tokyo, Japan.
Yasuhiro OtomoTrauma and Acute Critical Care Center, Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan.
Kohji OkamotoDepartment of Surgery, Center for Gastroenterology and Liver Disease, Kitakyushu City Yahata Hospital, Kitakyushu, Japan.
Yutaka UmemuraDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Joji KotaniDepartment of Disaster and Emergency Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Yuichiro SakamotoEmergency and Critical Care Medicine, Saga University Hospital, Saga, Japan.
Junichi SasakiDepartment of Emergency and Critical Care Medicine, Keio University School of Medicine, Tokyo, Japan.
Shin-Ichiro ShiraishiDepartment of Emergency and Critical Care Medicine, Aizu Chuo Hospital, Aizuwakamatsu, Japan.
Kiyotsugu TakumaEmergency & Critical Care Center, Kawasaki Municipal Kawasaki Hospital, Kawasaki, Japan.
Ryosuke TsurutaAdvanced Medical Emergency & Critical Care Center, Yamaguchi University Hospital, Ube, Japan.
Akiyoshi HagiwaraCenter Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
Kazuma YamakawaDivision of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.
Tomohiko MasunoDepartment of Emergency and Critical Care Medicine, Nippon Medical School, Tokyo, Japan.
Naoshi TakeyamaAdvanced Critical Care Center, Aichi Medical University Hospital, Nagakute, Japan.
Norio YamashitaAdvanced Emergency Medical Service Center Kurume University Hospital, Kurume, Japan.
Hiroto IkedaDepartment of Emergency Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Masashi UeyamaDepartment of Trauma, Critical Care Medicine, and Burn Center, Japan Community Healthcare Organization, Chukyo Hospital, Nagoya, Japan.
Satoshi FujimiDivision of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.
Satoshi GandoDivision of Acute and Critical Care Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
JAAM FORECAST group
Osaka Prefectural Medical Center · JPChiba University · JPHokkaido University · JPKeio University · JPKitakyushu City Hospital Organization · JPKurume University Hospital · JPSaga University · JPTohoku University · JPUniversity of Occupational and Environmental Health Japan · JPUniversity of Tsukuba · JPAichi Medical University Hospital · JPJapan Community Healthcare Organization · JPKameda Medical Center · JPKawasaki Hospital · JPKobe University · JPKyorin University · JPNational Center for Global Health and Medicine · JPSt. Luke's International Hospital · JPYamaguchi University Hospital · JP

Funding

Japanese Association for Acute Medicine 2014-01
6 · The paper itself

Abstract

backgroundSepsis is a leading cause of death and long-term disability in developed countries. A comprehensive report on the incidence, clinical characteristics, and evolving management of sepsis is important. Thus, this study aimed to evaluate the characteristics, management, and outcomes of patients with severe sepsis in Japan.

methodsThis is a cohort study of the Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis, and Trauma (FORECAST) study, which was a multicenter, prospective cohort study conducted at 59 intensive care units (ICUs) from January 2016 to March 2017. We included adult patients with severe sepsis based on the sepsis-2 criteria.

resultsIn total, 1184 patients (median age 73 years, interquartile range (IQR) 64-81) with severe sepsis were admitted to the ICU during the study period. The most common comorbidity was diabetes mellitus (23%). Moreover, approximately 63% of patients had septic shock. The median Sepsis-related Organ Failure Assessment (SOFA) score was 9 (IQR 6-11). The most common site of infection was the lung (31%). Approximately 54% of the participants had positive blood cultures. The compliance rates for the entire 3-h bundle, measurement of central venous pressure, and assessment of central venous oxygen saturation were 64%, 26%, and 7%, respectively. A multilevel logistic regression model showed that closed ICUs and non-university hospitals were more compliant with the entire 3-h bundle. The in-hospital mortality rate of patients with severe sepsis was 23% (21-26%). Older age, multiple comorbidities, suspected site of infection, and increasing SOFA scores correlated with in-hospital mortality, based on the generalized estimating equation model. The length of hospital stay was 24 (12-46) days. Approximately 37% of the patients were discharged home after recovery.

conclusionOur prospective study showed that sepsis management in Japan was characterized by a high compliance rate for the 3-h bundle and low compliance rate for central venous catheter measurements. The in-hospital mortality rate in Japan was comparable to that of other developed countries. Only one third of the patients were discharged home, considering the aging population with multiple comorbidities in the ICUs in Japan.

trial registrationUMIN-CTR, UMIN000019742 . Registered on 16 November 2015.

Indexed as

Hospital MortalityAgedAged, 80 and overCohort StudiesFemaleHumansIntensive Care UnitsJapanLogistic ModelsMaleMiddle AgedProspective StudiesSepsisTreatment OutcomeBundleElderlyResuscitationSepsis

Identifiers

PMID30466493
PMCPMC6251147
OpenAlexW2900478597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.